Share this post on:

Product Name :
Insulin glargine biosimilar(Shandong New Time Pharmaceutical)

Search keywords :
Insulin glargine

drugId :
null

Target Vo:
Insulin receptor

Target Vo Short Name :
INSR

Moa_Name:
Insulin receptor agonists

First Approval Country :
Mainland China

First Approval Date Filter:
2022

Origin Company_Name :
Lunan Pharmaceutical Group Co

Active Company_Name :
Shandong New Time Pharmaceutical Co Ltd

Active Indication_Name:
Diabetes Mellitus

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ras Antibody
YB1 Antibody
PKC eta Antibody: PKC eta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 78 kDa, targeting to PKC eta. It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related